Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19208
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaramanakos, P. N.en
dc.contributor.authorPappas, P.en
dc.contributor.authorMarselos, M.en
dc.date.accessioned2015-11-24T18:57:48Z-
dc.date.available2015-11-24T18:57:48Z-
dc.identifier.issn0928-1231-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19208-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectAntiparkinson Agents/*adverse effectsen
dc.subjectChlorpheniramine/*therapeutic useen
dc.subjectDyskinesia, Drug-Induced/*drug therapy/etiologyen
dc.subjectLevodopa/*adverse effectsen
dc.subjectParkinson Disease/*drug therapyen
dc.subjectSerotonin Receptor Agonists/*therapeutic useen
dc.titlePossible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's diseaseen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1007/s11096-007-9138-7-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17597418-
heal.identifier.secondaryhttp://www.springerlink.com/content/6115214433727j22/fulltext.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2008-
heal.journalNamePharm World Scien
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Karamanakos-2008-Possible role for ch.pdf107.01 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons